000147634 001__ 147634
000147634 005__ 20240229123025.0
000147634 0247_ $$2doi$$a10.2174/1871530319666191115114023
000147634 0247_ $$2pmid$$apmid:31729295
000147634 0247_ $$2ISSN$$a1871-5303
000147634 0247_ $$2ISSN$$a2212-3873
000147634 037__ $$aDKFZ-2019-02625
000147634 041__ $$aeng
000147634 1001_ $$aAkdad, Mourad$$b0
000147634 245__ $$aStudy of antihypertensive activity of Anvillea radiata in L-NAME-induced hypertensive rats and HPLC-ESI-MS analysis.
000147634 260__ $$aSharjah$$bBentham Science Publ.$$c2020
000147634 3367_ $$2DRIVER$$aarticle
000147634 3367_ $$2DataCite$$aOutput Types/Journal article
000147634 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1611668390_27391
000147634 3367_ $$2BibTeX$$aARTICLE
000147634 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147634 3367_ $$00$$2EndNote$$aJournal Article
000147634 500__ $$a2020;20(7):1059-1072
000147634 520__ $$aThis study aimed to evaluate the effect of the aqueous extract of Anvillea radiate (A. radiata) aerial parts (AEAR) on arterial blood pressure in normotensive and hypertensive rats.The effect of the acute and sub-chronic administration of AEAR on the following blood pressure parameters: systolic blood pressure (SBP), mean blood pressure (MBP), diastolic blood pressure (DBP), and heart rate (HR) was evaluated in normotensive and L-NAME induced hypertensive rats. In the second experiment the vasorelaxant effect of AEAR was assessed in isolated rat aortic rings with functional endothelium pre-contracted with epinephrine (EP) or KCl, and six antagonists/inhibitors were used to explore the mechanisms of action involved in the vasorelaxant effect. In order to determine the phytochemical contents of Anvillea radiata HPLC-ESI-MS analysis was conducted.Daily oral administration of AEAR (100 mg/kg) provoked a significant decrease in SBP, MBP, and DBP without affecting HR in hypertensive rats. In addition, AEAR (0.08-0.64 mg/ml) revealed a vasorelaxant effect in thoracic aortic rings pre-contracted by EP (10 µM) or KCl (80 mM). This effect was reduced in the presence of Nifedipine, L-Name or Methylene blue. The polyphenolic compounds of AEAR were determined.This study revealed that AEAR possesses a potent antihypertensive activity and its vasorelaxant activity seems to be mediated through Ca2+ channels, direct nitric oxide (NO), and NO/cGMP pathways. Chlorogenic acid and caffeic acid identified in A. radiata could be at least partially responsible for the antihypertensive activity of this extract.
000147634 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000147634 588__ $$aDataset connected to CrossRef, PubMed,
000147634 7001_ $$aAjebli, Mohammed$$b1
000147634 7001_ $$0P:(DE-He78)b00af8517028139fced3dda100c21c83$$aBreuer, Andrea$$b2$$udkfz
000147634 7001_ $$aKhallouki, Farid$$b3
000147634 7001_ $$0P:(DE-He78)43996fb100428b0d99e233c3261f7187$$aOwen, Robert W$$b4$$udkfz
000147634 7001_ $$aEddouks, Mohamed$$b5
000147634 773__ $$0PERI:(DE-600)2254157-3$$a10.2174/1871530319666191115114023$$gVol. 19$$n7$$p1059-1072$$tEndocrine, metabolic & immune disorders, drug targets$$v20$$x1871-5303$$y2020
000147634 909CO $$ooai:inrepo02.dkfz.de:147634$$pVDB
000147634 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bENDOCR METAB IMMUNE : 2017
000147634 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147634 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147634 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147634 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147634 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147634 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000147634 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings
000147634 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000147634 9141_ $$y2020
000147634 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b00af8517028139fced3dda100c21c83$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000147634 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)43996fb100428b0d99e233c3261f7187$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000147634 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000147634 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000147634 980__ $$ajournal
000147634 980__ $$aVDB
000147634 980__ $$aI:(DE-He78)C120-20160331
000147634 980__ $$aUNRESTRICTED